{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:05:18Z","timestamp":1788847518168,"version":"build-2803163510"},"reference-count":21,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health within the research line \u201cPrecision, gender and ethnicity-based medicine and geroscience: genetic-molecular mechanisms in the development, characterization and treatment of tumors\u201d","award":["GR-2018-12365278"],"award-info":[{"award-number":["GR-2018-12365278"]}]},{"name":"Italian Ministry of Health","award":["GR-2018-12365278"],"award-info":[{"award-number":["GR-2018-12365278"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>ETV6::ABL1 rearranged neoplasms are rare hematological diseases. To date, about 80 cases have been reported, including myeloid and lymphoid leukemias. The ETV6 gene codes for an ETS family transcription factor and several fusion partners have been described. When translocated, ETV6 causes the constitutive activation of the partner genes. Here, we report the case of a 54-year-old woman with a cryptic insertion of the 3\u2032 region of ABL1 in the ETV6 gene. The patient was first diagnosed with idiopathic hypereosinophilic syndrome, according to the clinical history, conventional cytogenetics, standard molecular analyses and pathologist description. Next generation sequencing of diagnosis samples unexpectedly detected both ETV6::ABL1 type A and B fusion transcripts, which were then confirmed by FISH. The diagnosis was Myeloid\/Lymphoid neoplasm with ETV6::ABL1 fusion, and the patient received imatinib mesylate treatment. In a follow-up after more than one year, the patient still maintained the molecular and complete hematological responses. This case highlights the importance of timely and proper diagnostics and prompt tyrosine kinase inhibitor treatment.<\/jats:p>","DOI":"10.3390\/ijms25010118","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T03:36:17Z","timestamp":1703129777000},"page":"118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment"],"prefix":"10.3390","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9299-9189","authenticated-orcid":false,"given":"Maria Teresa","family":"Bochicchio","sequence":"first","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6309-0515","authenticated-orcid":false,"given":"Giovanni","family":"Marconi","sequence":"additional","affiliation":[{"name":"Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3796-6418","authenticated-orcid":false,"given":"Carmen","family":"Baldazzi","sequence":"additional","affiliation":[{"name":"Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Bandini","sequence":"additional","affiliation":[{"name":"Istituto di Ematologia \u201cSer\u00e0gnoli\u201d, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4330-6320","authenticated-orcid":false,"given":"Francesca","family":"Ruggieri","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40100 Bologna, BO, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-5311","authenticated-orcid":false,"given":"Alessandro","family":"Lucchesi","sequence":"additional","affiliation":[{"name":"Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Agostinelli","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40100 Bologna, BO, Italy"},{"name":"Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4136-3591","authenticated-orcid":false,"given":"Elena","family":"Sabattini","sequence":"additional","affiliation":[{"name":"Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Orsatti","sequence":"additional","affiliation":[{"name":"Haematopathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, BO, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-9906","authenticated-orcid":false,"given":"Anna","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Capirossi","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Servili","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Ghelli Luserna di Ror\u00e0","sequence":"additional","affiliation":[{"name":"Fondazione Pisana per la Scienza ONLUS, 56017 San Giuliano Terme, PI, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1025-4210","authenticated-orcid":false,"given":"Giovanni","family":"Martinelli","sequence":"additional","affiliation":[{"name":"Scientific Directorate, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-969X","authenticated-orcid":false,"given":"Giorgia","family":"Simonetti","sequence":"additional","affiliation":[{"name":"Biosciences Laboratory, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianantonio","family":"Rosti","sequence":"additional","affiliation":[{"name":"Hematology Unit, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, FC, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.leukres.2012.04.010","article-title":"ETV6 Fusion Genes in Hematological Malignancies: A Review","volume":"36","author":"Morel","year":"2012","journal-title":"Leuk. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3324\/haematol.2016.144345","article-title":"Characterization of Leukemias with ETV6-ABL1 Fusion","volume":"101","author":"Zaliova","year":"2016","journal-title":"Haematologica"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergen.2019.07.004","article-title":"Chronic Myelomonocytic Leukemia with ETV6-ABL1 Rearrangement and SMC1A Mutation","volume":"238","author":"Cessna","year":"2019","journal-title":"Cancer Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41375-023-01958-1","article-title":"Myeloid\/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions: Reevaluation of the Defining Characteristics in a Registry-Based Cohort","volume":"37","author":"Metzgeroth","year":"2023","journal-title":"Leukemia"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Qi, Z., Smith, C., Shah, N.P., and Yu, J. (2023). Complex Genomic Rearrangements Involving ETV6::ABL1 Gene Fusion in an Individual with Myeloid Neoplasm. Genes, 14.","DOI":"10.3390\/genes14101851"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3343\/alm.2017.37.1.77","article-title":"A Case of Chronic Myeloid Leukemia with Rare Variant Etv6\/Abl1 Rearrangement","volume":"37","author":"Choi","year":"2017","journal-title":"Ann. Lab. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.seminhematol.2017.04.005","article-title":"ETV6 in Hematopoiesis and Leukemia Predisposition","volume":"54","author":"Hock","year":"2017","journal-title":"Semin. Hematol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Amarante-Mendes, G.P., Rana, A., Datoguia, T.S., Hamerschlak, N., and Brumatti, G. (2022). BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14010215"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cancergen.2018.08.002","article-title":"Myeloproliferative Neoplasm with ABL1\/ETV6 Rearrangement Mimics Chronic Myeloid Leukemia and Responds to Tyrosine Kinase Inhibitors","volume":"228","author":"Xie","year":"2018","journal-title":"Cancer Genet."},{"key":"ref_10","first-page":"1147","article-title":"P210BCR\/ABL, P190BCR\/ABL, and TEL\/ABL Activate Similar Signal Transduction Pathways in Hematopoietic Cell Lines","volume":"13","author":"Okuda","year":"1996","journal-title":"Oncogene"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Tirado, C.A., Siangchin, K., Shabsovich, D.S., Sharifian, M., and Schiller, G. (2016). A Novel Three-Way Rearrangement Involving ETV6 (12p13) and ABL1 (9q34) with an Unknown Partner on 3p25 Resulting in a Possible ETV6-ABL1 Fusion in a Patient with Acute Myeloid Leukemia: A Case Report and a Review of the Literature. Biomark. Res., 4.","DOI":"10.1186\/s40364-016-0070-7"},{"key":"ref_12","first-page":"789","article-title":"Clonal Eosinophils Are a Morphologic Hallmark of ETV6\/ABL1 Positive Acute Myeloid Leukemia","volume":"87","author":"Trubia","year":"2002","journal-title":"Haematologica"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1755-8166-6-39","article-title":"Myeloproliferative Neoplasm with ETV6-ABL1 Fusion: A Case Report and Literature Review","volume":"6","author":"Gancheva","year":"2013","journal-title":"Mol. Cytogenet."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1182\/blood.V97.8.2440","article-title":"ARG Tyrosine Kinase Activity Is Inhibited by STI571","volume":"97","author":"Okuda","year":"2001","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.leukres.2009.03.011","article-title":"Myeloproliferative Disorder with Eosinophilia and ETV6-ABL Gene Rearrangement: Efficacy of Second-Generation Tyrosine Kinase Inhibitors","volume":"33","author":"Nand","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ajh.25825","article-title":"Response to Tyrosine Kinase Inhibitors in Myeloid Neoplasms Associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 Fusion Genes","volume":"95","author":"Schwaab","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_17","first-page":"50","article-title":"An ETV6-ABL1 Fusion in a Patient with Chronic Myeloproliferative Neoplasm: Initial Response to Imatinib Followed by Rapid Transformation into ALL","volume":"6","author":"Kakadia","year":"2016","journal-title":"Leuk. Res. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1365-2141.2003.04391.x","article-title":"Clinical and Genetic Studies of ETV6\/ABL1-Positive Chronic Myeloid Leukaemia in Blast Crisis Treated with Imatinib Mesylate","volume":"122","author":"Barbouti","year":"2003","journal-title":"Br. J. Haematol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.humpath.2022.03.008","article-title":"Myeloid Nuclear Differentiation Antigen: An Aid in Differentiating Lymphoplasmacytic Lymphoma and Splenic Marginal Zone Lymphoma in Bone Marrow Biopsies at Presentation","volume":"124","author":"Righi","year":"2022","journal-title":"Hum. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jcp-2022-208425","article-title":"Performance Evaluation and Clinical Impact of the Oncomine Myeloid Research Assay for Gene Expression Analysis in Myeloid Haematologic Malignancies","volume":"76","author":"Jeon","year":"2022","journal-title":"J. Clin. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/cncr.31837","article-title":"Aneuploid Acute Myeloid Leukemia Exhibits a Signature of Genomic Alterations in the Cell Cycle and Protein Degradation Machinery","volume":"125","author":"Simonetti","year":"2019","journal-title":"Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/1\/118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:39:18Z","timestamp":1760132358000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/1\/118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["ijms25010118"],"URL":"https:\/\/doi.org\/10.3390\/ijms25010118","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]}}}